RUTGERS UNIVERSITY Researchers from Rutgers Robert Wood Johnson Medical School’s Department of Neurology have traced a previously observed link between microscopic organisms in the digestive tract — collectively known as the gut microbiome — and multiple sclerosis (MS). Their study in genetically altered miceand people supports the belief that dietary adjustments such as increased fiber may slow...
Tag: <span>Multiple sclerosis</span>
Post
Light therapy relieves fatigue syndrome in Multiple Sclerosis
MEDICAL UNIVERSITY OF VIENNA Multiple Sclerosis (MS) is almost always accompanied by fatigue, a massive tiredness that is described by the vast majority of patients as the most distressing symptom. In a recent scientific study, a research group led by Stefan Seidel from the Department of Neurology at MedUni Vienna and AKH Vienna identified light...
Post
New study identifies connection between diabetes medications, multiple sclerosis
UNIVERSITY OF ARIZONA HEALTH SCIENCES IMAGE: A NEW STUDY FOUND THAT ANTI-HYPERGLYCEMIC MEDICATIONS USED TO TREAT TYPE 2 DIABETES RESULTED IN AN INCREASED RISK OF MULTIPLE SCLEROSIS FOR PEOPLE OLDER THAN 45, PARTICULARLY AMONG WOMEN. CREDIT: GETTY IMAGES TUCSON, Arizona — A new University of Arizona Health Sciences study found that people older than 45 whose Type...
Post
S1P transporter could be crucial in the development of therapeutics for the treatment of Multiple Sclerosis
NATIONAL UNIVERSITY OF SINGAPORE, YONG LOO LIN SCHOOL OF MEDICINE Multiple sclerosis (MS) is an autoimmune disease affecting the brain and spinal cord. In MS, the activated immune cells attack myelin, a protective layer surrounding nerve cells, which disrupts the transmission of nerve impulses along nerve cells. Over time, there is permanent damage or deterioration...
Post
Can MS Be Stopped Early in its Tracks?
Kelli Whitlock Burton October 31, 2022 Dimethyl fumarate (DMF) could delay — or even prevent — clinical symptoms in patients with radiologically isolated syndrome (RIS), the earliest detected pre-clinical phase of multiple sclerosis. Researchers found that DMF reduced the risk of a first acute or progressive event related to CNS demyelination by more than 80% compared with...
Post
Specialist explains why multiple sclerosis can be misdiagnosed
by Laura Hegwer, Rush University Medical Center Credit: Pixabay/CC0 Public Domain Every five minutes, someone in the world receives the life-changing news that they have multiple sclerosis, a chronic disease in which the immune system attacks the protective layer of the nerves and causes lesions, or scars, in the brain and spinal cord. If you’re...
Post
Bolstering the blood-CNS barrier could lead to new treatment approach for multiple sclerosis
by Jennifer Michalowski, University of Utah Health Sciences Graphical abstract. Credit: Neuron (2022). DOI: 10.1016/j.neuron.2022.07.015 Millions of people worldwide are living with multiple sclerosis (MS), a disease in which the immune system attacks cells in the central nervous system (CNS), causing unpredictable symptoms that can include tremors, weakness, vision problems, and fatigue. Treatments for MS aim to...
Post
Multiple sclerosis drug works in a surprising way
Drugs called interferon betas are common treatments for multiple sclerosis (MS), reducing relapses and slowing motor function decline. Interferon beta, a protein known to contain a zinc binding pocket, is thought to reduce proinflammatory molecules and even increase production of anti-inflammatory species in MS patients. But researchers now report in ACS Chemical Neuroscience that the molecule reduces the...
Post
Virtual reality technology could strengthen effects of traditional rehabilitation for multiple sclerosis
by Kessler Foundation Dr. Carly Wender supervises a research participant in a VR exercise training study at Kessler Foundation. Credit: Kessler Foundation/Jody Banks In a recent article, Kessler Foundation scientists advocated for the incorporation of virtual reality (VR) technology in cognitive rehabilitation research in multiple sclerosis (MS). They presented a conceptual framework supporting VR as...
Post
Turncoat T cells are at the core of multiple sclerosis and other inflammatory central nervous system disorders
by Delthia Ricks, Medical Xpress scRNAseq replicates. CD45.1+ P14 cells were adoptively transferred into adult CD45.2+ GP or GFAP:GP mice 24h before i.c. infection with rLCMV-GP33. At least six weeks later, mice were treated with antiCD8a depleting antibody or isotype control. One week after depletion, mice were treated with TAM i.p. for four consecutive days...